[Bell2Bell] Podcast Featuring Amir Reichman, CEO

July 11, 2023 - The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries. Bell2Bell’s latest podcast features Amir Reichman, CEO of BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV). BiondVax’s pipeline is based on an innovative platform technology of alpaca-derived nanosized antibodies, known as Nanobodies or NanoAbs, addressing infectious and autoimmune diseases with large unmet medical needs such as COVID-19, psoriasis, psoriatic arthritis, asthma and macular degeneration.

Links to interview on Bell2Bell’s platform: https://podcast.bell2bell.com/e/bell2bell-podcast-featuring-amir-reichman-ceo-of-biondvax-pharmaceuticals-ltd-nasdaq-bvxv/